Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.

Abstract

5-Fluorocytosine transport may be a limiting factor for this therapeutic procedure. Quantitation with PET has to rely more on dynamic studies and modeling, including HPLC analysis of the plasma, than on nonmodeling approaches.